Non-Invasive Mechanical Ventilation reduces the Motor Decline in Amyotrophic Lateral Sclerosis
Grassano, M.; Koumantakis, E.; Manera, U.; Canosa, A.; Vasta, R.; Palumbo, F.; Fuda, G.; Salamone, P.; Marchese, G.; Casale, F.; Charrier, L.; Mora, G.; Moglia, C.; Calvo, A.; Chio, A.
Show abstract
BackgroundNon-invasive mechanical ventilation (NIMV) improves Amyotrophic Lateral Sclerosis (ALS) quality of life and survival. However, data about its effect on disease progression are still lacking. ObjectiveTo test whether NIMV use changed the rate of functional decline among ALS patients. MethodsIn this retrospective observational study, we included 465 ALS patients followed up at the ALS Center in Turin, Italy, who underwent NIMV during the disease course. The primary outcome was the change in functional decline after NIMV initiation when adjusting for covariates. Functional decline was based on the non-respiratory items of the ALS Functional Rating Score - Revised (ALSFRS-R). ResultsA slower progression of functional decline followed NIMV initiation (mean improvement 0.13, 95%CI 0.11 to 0.16, p<0.001) regardless of sex, age at diagnosis, and disease duration prior to NIMV initiation. Indeed, the disease stage at NIMV initiation (early or advanced) did not influence the results. Respiratory support exerts its slowing effect mainly on the progression of spinal motor function. ConclusionsWe proved that NIMV influences the rate of motor progression in ALS. This result was not a consequence of the ALSFRS-R floor effect. The functional decline slowed after starting NIMV independently of the site of disease onset. Our results reinforce the importance of not delaying NIMV initiation in all ALS patients. NIMV-induced slowing of disease progression should also be accounted for when evaluating clinical trial outcomes.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Skeletal muscle biomarkers of amyotrophic lateral sclerosis: a large-scale, multi-cohort proteomic study 92%
- Elevated plasma phosphorylated tau 181 in amyotrophic lateral sclerosis relates to lower motor neuron dysfunction 92%
- The age at onset of LRRK2 p.Gly2019Ser Parkinson's disease across ancestries and countries of origin 90%
Similar papers in this journal
- The oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling, and therapeutic implications 93%
- Spinal Cord Motor Neuron Phenotypes and Polygenic Risk Scores in Sporadic Amyotrophic Lateral Sclerosis: Deciphering the Disease Pathology and Therapeutic Potential of Ropinirole Hydrochloride 91%
- Predicting loss of independence and mortality in frontotemporal lobar degeneration syndromes 89%
Similar papers in this journal
- Peripherin: a novel early diagnostic and prognostic plasmatic biomarker in Amyotrophic Lateral Sclerosis 94%
- Nusinersen in adult patients with 5q spinal muscular atrophy: a multicenter observational cohorts’ study 93%
- Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients 90%
Similar papers in this journal
Similar papers in this journal
- Validation of Serum Neurofilaments as Prognostic & Potential Pharmacodynamic Biomarkers for ALS 92%
- Serum NfL in spinocerebellar ataxia type 1 is increased already at the preataxic stage, correlating with proximity to clinical onset 89%
- Novel associations of BST1 and LAMP3 with rapid eye movement sleep behavior disorder 87%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.